NCT05467800
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05467800
Title Study of Canakinumab in Patients With Myelofibrosis
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors John Mascarenhas
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles California 90048 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
The University of Kansas Cancer Center-Westwood Westwood Kansas 66205 United States Details
Ruttenberg Treatment Center New York New York 10029 United States Details
Atrium Health Levine Cancer Institute Charlotte North Carolina 28204 United States Details
Wake Forest Baptist Health Comprehensive Cancer Center Winston-Salem North Carolina 27157 United States Details
Cleveland Clinic Foundation Cleveland Ohio 44195 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field